Cagrilintide is a long-acting amylin analogue developed to support weight management and metabolic regulation. It mimics the hormone amylin, which is naturally secreted alongside insulin and plays a role in regulating appetite, slowing gastric emptying, and promoting satiety.

Potential Benefits (Based on Existing Research)

Cagrilintide has been researched for its potential to:

• Promote appetite suppression and enhance satiety
• Aid in weight management, especially when paired with GLP-1 agonists like Semaglutide
• Support metabolic control and glucose regulation
• Improve outcomes in obesity-related clinical trials

Note: Benefits listed are based on early-stage clinical trials and pre-approval studies. These are not FDA-approved uses.